Revised Cardiac Risk Index (RCRI) Calculator
Calculate the original six-item Lee RCRI point score and class for adult preoperative assessment before noncardiac surgery, with source-specific limitations.
Content updated: View sources
QuickMedCalc is developed and maintained by an independent developer. Medical content is not independently reviewed by a physician.
Formula and medical content are based on the references listed on this page. See sources, About, and Sources and Review Process.
Model scope: use this original six-item Lee RCRI only for adult preoperative assessment before noncardiac surgery. The original cohort included patients aged 50 years and older undergoing stable, nonurgent major noncardiac operations. This page does not verify that a patient or procedure matches that cohort and is not a pediatric, cardiac-surgery, urgent-surgery, or surgical-clearance tool. It is not a diagnostic tool. Every criterion and the creatinine unit must be entered explicitly; no unanswered item is treated as No.
About
This page reproduces the classic six-item Revised Cardiac Risk Index (RCRI) derived by Lee and colleagues for adults having major noncardiac surgery. The original 4,315-person study enrolled patients aged 50 years and older undergoing stable, nonurgent major noncardiac operations at one tertiary teaching hospital. It identified six independent predictors, each worth one point, for a historical composite of major cardiac complications. [1]
The classic arithmetic can be reproduced here, but the original cohorts do not establish the model for every adult age, urgent operation, pediatric patient, cardiac surgery, or postoperative diagnosis. This page summarizes risk factors; it does not provide medical clearance, decide whether surgery should proceed, or choose a test or treatment. It is not a direct measurement of myocardial injury. [1, 4]
Historical Lee validation rates and later Canadian estimates are shown separately because they use different populations, endpoints, surveillance, and time windows. A point total therefore does not map to one universal individual event percentage. [1, 2]
Formula
Interpretation
| RCRI group | Lee 1999 validation cohort | CCS 2017 pooled external estimates |
|---|---|---|
| 0 / Class I | 0.4% | 3.9% (95% CI 2.8–5.4) |
| 1 / Class II | 0.9% | 6.0% (95% CI 4.9–7.4) |
| 2 / Class III | 6.6% | 10.1% (95% CI 8.1–12.6) |
| ≥3 / Class IV | 11.0% | 15.0% (95% CI 11.1–20.0) |
Source-specific event estimates are shown separately for historical context; neither series is a universal individualized probability.
- RCRI group
- 0 / Class I
- Lee 1999 validation cohort
- 0.4%
- CCS 2017 pooled external estimates
- 3.9% (95% CI 2.8–5.4)
- RCRI group
- 1 / Class II
- Lee 1999 validation cohort
- 0.9%
- CCS 2017 pooled external estimates
- 6.0% (95% CI 4.9–7.4)
- RCRI group
- 2 / Class III
- Lee 1999 validation cohort
- 6.6%
- CCS 2017 pooled external estimates
- 10.1% (95% CI 8.1–12.6)
- RCRI group
- ≥3 / Class IV
- Lee 1999 validation cohort
- 11.0%
- CCS 2017 pooled external estimates
- 15.0% (95% CI 11.1–20.0)
Lee's validation values describe its original major-cardiac-complication endpoint in a 1,422-person validation cohort. The CCS estimates describe 30-day myocardial infarction, cardiac arrest, or death from external studies using systematic troponin measurement. They are not the same endpoint or detection strategy. These columns do not estimate the same outcome under the same detection strategy and must not be presented as a single updated probability table. [1, 2]
| Framework | Static context | What this page does not do |
|---|---|---|
| 2024 AHA/ACC | Validated tools are one part of a stepwise assessment; a general MACE risk of ≥1% is commonly described as elevated and RCRI >1 as a traditional calculated-risk entry point. [4] | No automatic test, biomarker, drug, or surgical decision. |
| 2022 ESC | ESC lists RCRI among available tools but does not recommend one universal score; urgency, symptoms, functional status, surgery, ECG, biomarkers, and clinical judgment remain part of the pathway. [6] | No silent conversion to another model or threshold. |
Current guideline context, kept separate from the classic score
- Framework
- 2024 AHA/ACC
- Static context
- Validated tools are one part of a stepwise assessment; a general MACE risk of ≥1% is commonly described as elevated and RCRI >1 as a traditional calculated-risk entry point. [4]
- What this page does not do
- No automatic test, biomarker, drug, or surgical decision.
- Framework
- 2022 ESC
- Static context
- ESC lists RCRI among available tools but does not recommend one universal score; urgency, symptoms, functional status, surgery, ECG, biomarkers, and clinical judgment remain part of the pathway. [6]
- What this page does not do
- No silent conversion to another model or threshold.
Modern corrections were checked separately. The AHA/ACC correction is retained as a source for the current online document; it does not change this page's six-item Lee arithmetic. The ESC correction supplies the external vascular-surgery validation context below rather than changing the classic runtime. [5, 7]
The six classic RCRI predictors
| Criterion | Original definition or example | Points | Important boundary | Current guideline distinction |
|---|---|---|---|---|
| High-risk surgery | Intraperitoneal, intrathoracic, or suprainguinal vascular surgery in the historical definition. | 1 | This is not a universal current procedure-risk label. | Current pathways assess exact operation, urgency, and surgical risk separately. |
| Ischemic heart disease | Prior myocardial infarction, positive exercise test, ischemic chest pain, nitrate therapy, or pathological Q waves in the original examples. | 1 | A history item; this page does not diagnose ischemia. | Symptoms, ECG, prior PCI/CABG, and other modifiers may matter now. |
| Congestive heart failure | Prior heart failure, pulmonary edema, paroxysmal nocturnal dyspnea, S3, rales, or pulmonary vascular redistribution in the original examples. | 1 | Do not infer it from one symptom or a current ejection fraction. | Current severity, symptoms, ventricular and valve disease need separate assessment. |
| Cerebrovascular disease | Prior stroke or transient ischemic attack. | 1 | The criterion is not a general neurologic screen. | The whole perioperative history and current neurologic status remain relevant. |
| Preoperative insulin therapy | Insulin treatment before surgery; diabetes without insulin does not score this item. | 1 | This is not a diabetes-severity scale. | Current medication, glucose, and comorbidity context are not added to classic RCRI. |
| Preoperative creatinine | Serum creatinine strictly greater than 2.0 mg/dL after the selected unit is normalized. | 1 | Exactly 2.0 mg/dL or 176.8 µmol/L scores 0. | Guideline summaries may display ≥2.0 mg/dL, but that does not change this runtime. |
- Criterion
- High-risk surgery
- Original definition or example
- Intraperitoneal, intrathoracic, or suprainguinal vascular surgery in the historical definition.
- Points
- 1
- Important boundary
- This is not a universal current procedure-risk label.
- Current guideline distinction
- Current pathways assess exact operation, urgency, and surgical risk separately.
- Criterion
- Ischemic heart disease
- Original definition or example
- Prior myocardial infarction, positive exercise test, ischemic chest pain, nitrate therapy, or pathological Q waves in the original examples.
- Points
- 1
- Important boundary
- A history item; this page does not diagnose ischemia.
- Current guideline distinction
- Symptoms, ECG, prior PCI/CABG, and other modifiers may matter now.
- Criterion
- Congestive heart failure
- Original definition or example
- Prior heart failure, pulmonary edema, paroxysmal nocturnal dyspnea, S3, rales, or pulmonary vascular redistribution in the original examples.
- Points
- 1
- Important boundary
- Do not infer it from one symptom or a current ejection fraction.
- Current guideline distinction
- Current severity, symptoms, ventricular and valve disease need separate assessment.
- Criterion
- Cerebrovascular disease
- Original definition or example
- Prior stroke or transient ischemic attack.
- Points
- 1
- Important boundary
- The criterion is not a general neurologic screen.
- Current guideline distinction
- The whole perioperative history and current neurologic status remain relevant.
- Criterion
- Preoperative insulin therapy
- Original definition or example
- Insulin treatment before surgery; diabetes without insulin does not score this item.
- Points
- 1
- Important boundary
- This is not a diabetes-severity scale.
- Current guideline distinction
- Current medication, glucose, and comorbidity context are not added to classic RCRI.
- Criterion
- Preoperative creatinine
- Original definition or example
- Serum creatinine strictly greater than 2.0 mg/dL after the selected unit is normalized.
- Points
- 1
- Important boundary
- Exactly 2.0 mg/dL or 176.8 µmol/L scores 0.
- Current guideline distinction
- Guideline summaries may display ≥2.0 mg/dL, but that does not change this runtime.
These six rows are the only runtime inputs. Current perioperative assessment may additionally consider procedure urgency, exact procedure risk, functional capacity or DASI, frailty, symptoms, severe valve disease, pulmonary hypertension, congenital heart disease, prior PCI or CABG, natriuretic peptides, troponin, biomarkers, and other risk modifiers; none is inferred here. [1, 4, 6]
Why the creatinine boundary is shown two ways
Lee 1999 used a strict serum-creatinine threshold greater than 2.0 mg/dL. Current AHA/ACC and ESC summary tables often print ≥2.0 mg/dL. This is a source-identity difference, not a reason to silently produce two scores: this page stays faithful to Lee, so exactly 2.0 mg/dL scores 0 and 176.8 µmol/L scores 0, while a value above the boundary scores one. Neither this binary item nor its conversion determines eGFR, creatinine clearance, CKD stage, renal function, or a medication dose. [1, 4, 6, 9]
Performance, modern cohorts, and vascular surgery
The original RCRI came from a single-center 1989–1994 cohort; later surgery, anesthesia, surveillance, and troponin practice changed the observed endpoint. Ford's systematic review found moderate overall discrimination and may be weaker in vascular surgery, while Fronczek's vascular validation reported a c-statistic of 0.60 and systematic underestimation before recalibration. These are reasons to interpret the model cautiously, not reasons to call it useless or to make this page calculate a replacement. [3, 8]
VISION research examined whether modern myocardial-injury detection and eGFR could update the renal variable. This page preserves the published creatinine item and does not mix eGFR, age, or troponin into the classic score. Low points do not mean zero risk, and high points do not make an event inevitable. [9]
RCRI is not another perioperative model
Gupta MICA, ACS NSQIP, SORT, and vascular-specific indices use different inputs, endpoints, time windows, and calibration. An RCRI point total cannot be converted into a Gupta or NSQIP percentage, and the creatinine-clearance or eGFR tools answer different renal questions. No alternative model is calculated or selected here. [3, 10]
A completed score is not medical clearance. Do not use it to approve, cancel, delay, or automatically accelerate an operation, or to order stress testing, CCTA, ECG, echocardiography, BNP, NT-proBNP, troponin, medication, or monitoring. Urgent operations require the applicable clinical team and pathway rather than delay for this calculator. [4, 6]
References
- Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–1049. PMID 10477528. DOI 10.1161/01.CIR.100.10.1043.
- Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33(1):17–32. PMID 27865641. DOI 10.1016/j.cjca.2016.09.008.
- Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the Revised Cardiac Risk Index. Ann Intern Med. 2010;152(1):26–35. PMID 20048269. DOI 10.7326/0003-4819-152-1-201001050-00007.
- Thompson A, Fleischmann KE, Smilowitz NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. Circulation. 2024;150(19):e351–e442. PMID 39316661. DOI 10.1161/CIR.0000000000001285.
- Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. PMID 39556658. DOI 10.1161/CIR.0000000000001298.
- Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):3826–3924. PMID 36017553. DOI 10.1093/eurheartj/ehac270.
- Correction to: 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. PMID 37675631. DOI 10.1093/eurheartj/ehad577.
- Fronczek J, Polok K, Devereaux PJ, et al. External validation of the Revised Cardiac Risk Index and National Surgical Quality Improvement Program Myocardial Infarction and Cardiac Arrest calculator in noncardiac vascular surgery. Br J Anaesth. 2019;123(4):421–429. PMID 31256916. DOI 10.1016/j.bja.2019.05.029.
- Roshanov PS, Sessler DI, Chow CK, et al. External validation of the Revised Cardiac Risk Index and update of its renal variable to predict 30-day risk of major cardiac complications after non-cardiac surgery: rationale and plan for analyses of the VISION study. BMJ Open. 2017;7:e013510. PMID 28069624. PMCID PMC5223708. DOI 10.1136/bmjopen-2016-013510.
- Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011;124(4):381–387. PMID 21730309. DOI 10.1161/CIRCULATIONAHA.110.015701.
FAQ
It reproduces the original 1999 Lee Revised Cardiac Risk Index: six binary predictors are added to produce a 0–6 point total and original Class I–IV grouping. It does not generate surgical clearance, diagnose a cardiac condition, or choose a test, medicine, monitoring plan, or operation.
Sources: [1]
The six one-point criteria are high-risk surgery in the original definition, ischemic heart disease, congestive heart failure, cerebrovascular disease, preoperative insulin therapy for diabetes, and preoperative serum creatinine strictly above 2.0 mg/dL.
Sources: [1]
The source definitions include prior myocardial infarction, a positive exercise test, current chest pain considered due to myocardial ischemia or nitrate use, or pathologic Q waves. Prior coronary bypass or PCI alone did not automatically satisfy the historical definition unless qualifying findings were present after the procedure.
Sources: [1]
The source definitions include a history of heart failure or pulmonary edema, paroxysmal nocturnal dyspnea, an S3 or bilateral rales on examination, or pulmonary vascular redistribution on chest radiography. Use documented clinical information rather than inferring a diagnosis from this page.
Sources: [1]
The original item is present for a documented history of stroke or transient ischemic attack (TIA). This calculator does not diagnose either condition.
Sources: [1]
No. The original predictor is preoperative insulin therapy for diabetes. Diabetes treated without insulin does not score this specific historical item, although it can still be clinically important outside the RCRI arithmetic.
Sources: [1]
This page preserves the original Lee model’s strict greater-than boundary: exactly 2.0 mg/dL scores 0 and a value above 2.0 mg/dL scores 1. Some later guideline tables display a rounded ≥2.0 mg/dL boundary; that presentation is not silently substituted into the original equation here.
The original classes are Class I for 0 points, Class II for 1 point, Class III for 2 points, and Class IV for 3 or more points. The class is a historical model grouping, not a treatment or surgical-clearance category.
Sources: [1]
Observed rates depend on the population, operation mix, endpoint definition, follow-up, and surveillance method. The result shows the submitted score group beside the original 1999 validation observation and the later pooled estimate, but keeps them separate because they used different outcomes and detection strategies. Neither series is presented as one universal individualized event probability.
The original composite included myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block. Later studies and guidelines often report different composites such as 30-day death, myocardial infarction, or cardiac arrest, so the percentages are not interchangeable.
The derivation and validation cohort included patients aged 50 years and older undergoing stable, nonurgent major noncardiac surgery at one center. Use in broader adult populations is part of later clinical practice and validation, not a claim that the original cohort represented every patient or operation.
No. Current perioperative guidelines place validated tools within a broader stepwise assessment. Symptoms, urgency, functional status, frailty, procedure details, comorbidities, biomarkers when indicated, and patient preferences remain relevant; the point total alone does not issue a care instruction.
RCRI omits age, exact procedure type, functional capacity, frailty, surgery urgency, current symptoms, natriuretic peptides, troponin, and several contemporary variables. Its performance is moderate across mixed noncardiac surgery and can be weaker in vascular surgery; other validated tools, such as the Gupta myocardial infarction or cardiac arrest model, answer related but not identical questions.
Related Calculators
CrCl
Calculate adult creatinine clearance (CrCl) with the Cockcroft–Gault equation using age, an explicit weight basis, serum creatinine, and the published sex coefficient.
MAP
Calculate conventional mean arterial pressure from one paired systolic and diastolic blood-pressure reading, with pulse pressure and a transparent formula audit.
Framingham
Calculate the 2008 lipid-based Framingham Risk Score for 10-year General CVD in adults aged 30–74 without established cardiovascular disease.
Disclaimer
Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.